Compare SLRC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLRC | INMD |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 803.0M | 842.0M |
| IPO Year | 2007 | 2018 |
| Metric | SLRC | INMD |
|---|---|---|
| Price | $13.24 | $15.32 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $15.14 | ★ $17.33 |
| AVG Volume (30 Days) | 455.3K | ★ 827.0K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 10.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.09 | $1.74 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | $42.26 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.13 | $12.72 |
| 52 Week High | $16.75 | $16.74 |
| Indicator | SLRC | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 65.95 |
| Support Level | $12.83 | $13.27 |
| Resistance Level | $13.41 | $15.72 |
| Average True Range (ATR) | 0.26 | 0.32 |
| MACD | 0.12 | 0.07 |
| Stochastic Oscillator | 92.13 | 93.50 |
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.